UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Nature communications, 2021-03, Vol.12 (1), p.1402-1402, Article 1402

2021

Volltextzugriff (PDF)

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3311-3317

2023

Volltextzugriff (PDF)

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.1560-1568

2018

Volltextzugriff (PDF)

Sensitive Detection of Exosomal Proteins via a Compact Surface Plasmon Resonance Biosensor for Cancer Diagnosis

ACS sensors, 2018-08, Vol.3 (8), p.1471-1479

2018

Volltextzugriff (PDF)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

Case reports in oncology, 2019-01, Vol.12 (1), p.260-276

2019

Volltextzugriff (PDF)

Prolonged Disease Control Despite ALK Inhibitor Discontinuation in Advanced ALK-Positive NSCLC

European journal of case reports in internal medicine, 2024-04, Vol.11 (6), p.004527

2024

Volltextzugriff (PDF)

Small Cell Lung Cancer

Mayo Clinic proceedings, 2008-03, Vol.83 (3), p.355-367

2008

Volltextzugriff (PDF)

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

Frontiers in oncology, 2021-06, Vol.11, p.639745

2021

Volltextzugriff (PDF)

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

CA: a cancer journal for clinicians, 2013-07, Vol.63 (4), p.249-279

2013

Volltextzugriff (PDF)

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6145-6153

2008

Volltextzugriff (PDF)

The role of focal adhesion kinase in lung cancer

Anti-cancer agents in medicinal chemistry, 2013-05, Vol.13 (4), p.581-583

Dy, Grace K

2013

Volltextzugriff (PDF)

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002553

2021

Volltextzugriff (PDF)

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

The New England journal of medicine, 2021-06, Vol.384 (25), p.2371-2381

2021

Volltextzugriff (PDF)

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options

Cancer biology & medicine, 2016-03, Vol.13 (1), p.77-86

2016

Volltextzugriff (PDF)

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Frontiers in oncology, 2022-08, Vol.12, p.958043-958043

2022

Volltextzugriff (PDF)

Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor

Journal of thoracic oncology, 2015-09, Vol.10 (9), p.e89-e90

2015

Volltextzugriff (PDF)

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis

JTO clinical and research reports, 2023-06, Vol.4 (6), p.100522-100522, Article 100522

2023

Volltextzugriff (PDF)

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Journal of hepatology, 2012-01, Vol.56 (1), p.176-183

2012

Volltextzugriff (PDF)

Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis

ACS nano, 2023-05, Vol.17 (9), p.8108-8122

2023

Volltextzugriff (PDF)

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

Clinical and translational science, 2021-03, Vol.14 (2), p.664-670

2021

Volltextzugriff (PDF)

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies

The oncologist (Dayton, Ohio), 2024-07

2024

Volltextzugriff (PDF)

First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel

International journal of nanomedicine, 2014-01, Vol.9 (Issue 1), p.209-221

2014

Volltextzugriff (PDF)

Complementary and Alternative Medicine Use by Patients Enrolled Onto Phase I Clinical Trials

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4810-4763

2004

Volltextzugriff (PDF)

CodeBreak 200: study limitations, and future directions

Translational cancer research, 2024-01, Vol.13 (1), p.15-21

2024

Volltextzugriff (PDF)

JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer

Cancer, 2022-01, Vol.128 (1), p.65-74

2022

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Englisch
(210)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(110)
Humans
(92)
Oncology
(88)
Female
(65)
Male
(61)
Middle Aged
(57)
Aged
(56)
Adult
(39)
Lung Neoplasms - Drug Therapy
(38)
Tumors
(32)
Aged, 80 And Over
(30)
Biological And Medical Sciences
(30)
Lung Cancer
(30)
Medical Sciences
(30)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(29)
Lung Neoplasms - Pathology
(24)
Treatment Outcome
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Respiratory System
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Sensitive Detection of Exosomal Proteins via a Compact Surface Plasmon Resonance Biosensor for Cancer Diagnosis

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

Prolonged Disease Control Despite ALK Inhibitor Discontinuation in Advanced ALK-Positive NSCLC

Small Cell Lung Cancer

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

The role of focal adhesion kinase in lung cancer

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies

First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel

Complementary and Alternative Medicine Use by Patients Enrolled Onto Phase I Clinical Trials

CodeBreak 200: study limitations, and future directions

JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer

Suchergebnisse filtern